Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Bunce

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Substance Use & Misuse|May 31, 2021
Effectiveness and Utility of Mobile Device Assessment of Subjective Craving during Residential Opioid Dependence TreatmentH Harrington Cleveland, Kyler S Knapp, Timothy R Brick, et al.
The Journal of Clinical Investigation|March 13, 2013
Biochemical correlates of neuropsychiatric illness in maple syrup urine diseaseEmilie R Muelly, Gregory J Moore, Scott C Bunce, et al.
Brain Research Bulletin|September 19, 2022
Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorderDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Brain Research Bulletin|February 16, 2016
Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependenceAndrew S Huhn, Jonathan Harris, H Harrington Cleveland, et al.
Journal of Addiction Medicine|December 4, 2014
Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patientsScott C Bunce, Jonathan D Harris, Edward O Bixler, et al.
Brain Research Bulletin|August 29, 2022
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking ratsBrianna Evans, Brooke Stoltzfus, Nikhil Acharya, et al.
Behavioural Pharmacology|June 2, 2026
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley ratsBrianna Evans, Nikhil Acharya, Christopher G Brandl, et al.
Substance Use & Misuse|March 21, 2025
Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential TreatmentDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Drug and Alcohol Dependence|August 15, 2021
Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatmentDahlia Mukherjee, Dean M Stankoski, Sarah E Tilden, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Substance Use & Misuse|May 31, 2021
Effectiveness and Utility of Mobile Device Assessment of Subjective Craving during Residential Opioid Dependence TreatmentH Harrington Cleveland, Kyler S Knapp, Timothy R Brick, et al.
The Journal of Clinical Investigation|March 13, 2013
Biochemical correlates of neuropsychiatric illness in maple syrup urine diseaseEmilie R Muelly, Gregory J Moore, Scott C Bunce, et al.
Brain Research Bulletin|September 19, 2022
Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorderDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Brain Research Bulletin|February 16, 2016
Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependenceAndrew S Huhn, Jonathan Harris, H Harrington Cleveland, et al.
Journal of Addiction Medicine|December 4, 2014
Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patientsScott C Bunce, Jonathan D Harris, Edward O Bixler, et al.
Brain Research Bulletin|August 29, 2022
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking ratsBrianna Evans, Brooke Stoltzfus, Nikhil Acharya, et al.
Behavioural Pharmacology|June 2, 2026
Acute glucagon-like peptide-1 receptor agonist, semaglutide, attenuates cue-, drug-, and stress-induced fentanyl seeking in male Sprague-Dawley ratsBrianna Evans, Nikhil Acharya, Christopher G Brandl, et al.
Substance Use & Misuse|March 21, 2025
Contemporaneous Link Between Pain and Craving in Patients Recovering from Prescription Opioid Use Disorder During Residential TreatmentDaniel J Petrie, Kyler S Knapp, Christopher S Freet, et al.
Addictive Behaviors|August 22, 2016
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugsDavid M Lydon-Staley, H Harrington Cleveland, Andrew S Huhn, et al.
Drug and Alcohol Dependence|August 15, 2021
Reregulation of cortisol levels and sleep in patients with prescription opioid use disorder during long-term residential treatmentDahlia Mukherjee, Dean M Stankoski, Sarah E Tilden, et al.
Pageof 3